1,2-Dibromo-1H-indole | 65216-78-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 1,2-Dibromo-1H-indole
• 英文别名: 1,2-dibromoindole
• CAS: 65216-78-6
• 化学式: C₈H₅Br₂N
• 分子量: 274.94
• InChiKey: UMAJKTMCQYQKJH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  4.9
• 氢给体数：
  0
• 氢受体数：
  0

文献信息

• Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
  申请人：——

  公开号：US20040043965A1

  公开（公告）日：2004-03-04

  Novel compounds useful as chemotherapeutic and chemopreventive agents are provided. The compounds are analogs of indole-3-carbinol metabolites wherein the structures and substituents of the compounds are selected to enhance the compounds' overall efficacy, particularly with respect to therapeutic activity, oral bioavailability, long-term safety, patient tolerability, and therapeutic window. The compounds are useful not only in treatment of cancer but also in prevention of cancer. One preferred class of the novel compounds have the structure of formula (I) 1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 are defined herein. Pharmaceutical compositions are provided as well, as are methods of synthesis and use.

  提供了作为化疗和化学预防剂有用的新化合物。这些化合物是吲哚-3-甲醇代谢物的类似物，其中化合物的结构和取代基被选择以增强化合物的整体功效，特别是在治疗活性、口服生物利用度、长期安全性、患者耐受性和治疗窗口方面。这些化合物不仅在癌症治疗中有用，而且在癌症预防中也有用。一类首选的新化合物具有以下结构式（I） 1 其中R 1 、R 2 、R 3 、R 4 、R 5 、R 6 、R 7 、R 8 、R 9 、R 10 、R 11 和R 12 在此定义。还提供了药物组合物，以及合成和使用方法。
• Analogs of Indole-3-Carbinol Metabolites as Chemotherapeutic and Chemopreventive Agents
  申请人：JONG Ling

  公开号：US20090023796A1

  公开（公告）日：2009-01-22

  Novel compounds useful as chemotherapeutic and chemopreventive agents are provided. The compounds are analogs of indole-3-carbinol metabolites wherein the structures and substituents of the compounds are selected to enhance the compounds' overall efficacy, particularly with respect to therapeutic activity, oral bioavailability, long-term safety, patient tolerability, and therapeutic window. The compounds are useful not only in treatment of cancer but also in prevention of cancer. One preferred class of the novel compounds has the structure of formula (IV) wherein: R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 5A , R 6A , R 7A , R 8A , R 22 and R 23 are defined herein. Pharmaceutical compositions are provided as well, as are methods of synthesis and use.

  提供了一种作为化疗和化学预防剂的新化合物。这些化合物是吲哚-3-甲醇代谢产物的类似物，其中这些化合物的结构和取代基被选择以增强这些化合物的整体功效，特别是治疗活性、口服生物利用度、长期安全性、患者耐受性和治疗窗口方面的功效。这些化合物不仅在癌症治疗方面有用，而且在癌症预防方面也有用。其中一类优选的新化合物具有公式（IV）的结构，其中：R1、R2、R3、R4、R5、R6、R7、R8、R5A、R6A、R7A、R8A、R22和R23在此被定义。此外，还提供了制药组合物、合成和使用方法。
• Process for the preparation of indigo compounds
  申请人：MITSUI TOATSU CHEMICALS, Inc.

  公开号：EP0335524A2

  公开（公告）日：1989-10-04

  An indigo compound is prepared by reacting an indole compound unsubstituted in the 2- and 3-­positions, with hydrogen peroxide in a liquid phase comprising an organic liquid. In one aspect, the liquid phase comprises at least two separate phases including an organic phase containing the indole compound and an aqueous phase containing hydrogen peroxide; in another aspect, the hydrogen peroxide is in solution in an organic solvent.

  一种靛蓝化合物的制备方法是：在由有机液体组成的液相中，使在 2 位和 3 位上未被取代的吲哚化合物与过氧化氢反应。在一个方面，液相至少包括两个独立的相，包括含有吲哚化合物的有机相和含有过氧化氢的水相；在另一方面，过氧化氢是在有机溶剂中的溶液。
• Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventative agents
  申请人：SRI International

  公开号：EP1623985A2

  公开（公告）日：2006-02-08

  Novel compounds useful as chemotherapeutic and chemopreventative agents are provided. The compounds are analogs of indole-3-carbinol metabolites wherein the structures and substituents of the compounds are selected to enhance the compounds' overall efficacy, particularly with respect to therapeutic activity, oral bioavailability, long-term safety, patient tolerability, and therapeutic window. The compounds are useful not only in treatment of cancer but also in prevention of cancer. One preferred class of the novel compounds has the structure of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are defined herein. Pharmacetical compositions are provided as well, as are methods of synthesis and use.

  本研究提供了可用作化疗和化疗预防剂的新型化合物。这些化合物是吲哚-3-甲醇代谢物的类似物，其中化合物的结构和取代基的选择是为了提高化合物的整体疗效，特别是在治疗活性、口服生物利用度、长期安全性、患者耐受性和治疗窗口方面。这些化合物不仅可用于治疗癌症，还可用于预防癌症。一类优选的新型化合物具有式 (I) 结构，其中 R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11 和 R12 在此定义。此外，还提供了药用组合物以及合成和使用方法。
• ANALOGS OF INDOLE-3-CARBINOL METABOLITES AS CHEMOTHERAPEUTIC AND CHEMOPREVENTIVE AGENTS
  申请人：Sri International

  公开号：EP1530572A2

  公开（公告）日：2005-05-18